How should Wellbutrin (bupropion) be titrated, including starting dose, increments, maximum dose, and special considerations for hepatic impairment, older adults, and seizure risk?

Wellbutrin Dose Titration

Start bupropion at 150 mg once daily in the morning for 3-4 days, then increase to 150 mg twice daily (or 300 mg once daily for extended-release formulations), with a maximum dose of 300 mg per day for most patients. 1, 2

Standard Titration Schedule

For Depression (Wellbutrin XL/Extended-Release)

• Days 1-4: 150 mg once daily in the morning
• Day 4 onward: Increase to 300 mg once daily (target dose)
• Maximum: 450 mg once daily (though 300 mg is the usual target) 2

For Smoking Cessation

• Days 1-3: 150 mg once daily in the morning
• Day 4 through 12 weeks: 150 mg twice daily if tolerated
• Maximum: 300 mg per day 1, 3
• Initiate dosing 1-2 weeks before the planned quit date 1

For Immediate-Release Formulations

• Starting: 37.5 mg every morning
• Titration: Increase by 37.5 mg every 3 days as tolerated
• Target: 150 mg twice daily
• Maximum: 450 mg per day in divided doses (given three times daily) 4
• Give the second dose before 3 PM to minimize insomnia risk 4

Critical Seizure Risk Mitigation

The single most important safety consideration is seizure prevention—gradual dose escalation is mandatory. 2

Absolute Contraindications (Do Not Prescribe)

• Current or prior seizure disorder
• Current or prior bulimia or anorexia nervosa
• Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs
• Patients with brain metastases or stroke
• Concurrent MAOI use (within 14 days) 1, 2

Seizure Risk Factors (Use Extreme Caution or Avoid)

• Severe head injury, arteriovenous malformation, CNS tumor or infection
• Concomitant medications that lower seizure threshold (antipsychotics, tricyclic antidepressants, theophylline, systemic corticosteroids)
• Metabolic disorders (hypoglycemia, hyponatremia, severe hepatic impairment, hypoxia)
• Diabetes treated with insulin or oral hypoglycemics
• Excessive alcohol use
• Illicit drug use (especially cocaine) or CNS stimulant abuse 2

The seizure incidence at recommended doses (≤450 mg/day) is approximately 0.1-0.4%, but increases nearly tenfold at doses between 450-600 mg/day. 5 Doses of 2.7 g and higher in overdose consistently cause seizures, encephalopathy, and cardiovascular effects 6.

Special Population Dosing

Hepatic Impairment

• Moderate to severe impairment: 150 mg every other day (maximum)
• Mild impairment: Consider reducing dose and/or frequency
• Bupropion is extensively metabolized; hepatic dysfunction significantly increases drug exposure 2

Renal Impairment

• Any degree of renal impairment: Consider reducing dose and/or frequency
• Monitor closely as active metabolites may accumulate 2

Older Adults (≥65 years)

• Start at approximately 50% of standard adult dose (e.g., 37.5-75 mg daily)
• Titrate more slowly—increase by increments of the initial dose every 5-7 days
• Target dose may be lower than in younger adults (e.g., 150 mg twice daily maximum) 4, 7
• Older adults are at higher risk for drug interactions and adverse effects due to polypharmacy 7

Monitoring and Management

Timing Considerations

• Insomnia prevention: Give second daily dose before 3 PM 4
• Smoking cessation: Begin 1-2 weeks before quit date to achieve steady-state levels 1

Blood Pressure Monitoring

• Check blood pressure before initiating treatment and periodically during therapy
• Bupropion can cause hypertension, particularly when combined with nicotine replacement therapy (6.1% incidence with combination vs. 2.5% with bupropion alone) 2
• In seasonal affective disorder trials, 2% developed hypertension requiring discontinuation 2

Neuropsychiatric Monitoring

• Monitor for agitation, depression worsening, mania/hypomania, psychosis, suicidal ideation
• Discontinue immediately if serious neuropsychiatric symptoms emerge 2
• Screen for bipolar disorder before initiating—bupropion can precipitate manic episodes 2

Duration of Treatment

• Depression: Continue for 4-12 months after first episode; longer for recurrent depression 7
• Smoking cessation: 7-12 weeks standard; may extend to 6-12 months for continued cessation support 1
• Reassess need for maintenance treatment periodically 2

Common Pitfalls to Avoid

1. Exceeding 300 mg per day without clear indication—seizure risk increases substantially above this dose
2. Rapid titration—always allow at least 3-4 days between dose increases
3. Prescribing to patients with eating disorders—absolute contraindication due to electrolyte abnormalities and seizure risk
4. Ignoring drug interactions—bupropion inhibits CYP2D6, increasing levels of many antidepressants, antipsychotics, and beta-blockers 2
5. Late-day dosing—causes insomnia; second dose must be before mid-afternoon
6. Combining with MAOIs—risk of hypertensive crisis; requires 14-day washout period 2
7. Failing to reduce dose in hepatic/renal impairment—significantly increases toxicity risk

Efficacy Timeline

• Antidepressant effect: Full therapeutic trial requires 4-8 weeks at target dose 4
• Smoking cessation: Benefits typically seen within the 7-12 week treatment period 1
• Some patients may experience rapid improvement in energy level within days to weeks 4